According to experts from London, women had a 50% greater chance than males of having long Covid.
People who were ill before the pandemic and those who are 50 to 60 years old are also more likely to report having long-lasting symptoms after catching Covid. Other risk factors include poor mental health before lockup, obesity, and asthma.
The study, which was published on Tuesday and was conducted by specialists at King’s College London and University College London, sought to clarify the prevalence of extended Covid and the risk factors for its occurrence.
They discovered that while nearly 5% of those with Covid may experience “debilitating” symptoms, up to 17% of those with Covid may go on to report long Covid.
Women were “more likely” to experience symptoms that persisted for more than four and 12 weeks.
There was “no indication” that black and minority ethnic persons were at increased risk, despite the fact that white people were.
Two million Britons according to the Office for National Statistics, had long Covid at the beginning of last month.
The Standard quoted King’s College researcher, Dr Ellen Thompson, as saying: “Defining these risk variables for long-term Covid frequency would assist in identifying people who have a higher possibility of experiencing symptoms weeks after infection.
“This will assist physicians in identifying patient populations that could react differently to various treatment plans.”
Long Covid is characterised by the presence of one or more Covid symptoms at least four weeks following infection.
But because the symptoms that have been used to characterise long-term COVID have changed between academic research, it has been more challenging to make generalisations regarding its frequency, effects on the general population, and future costs to society.
The study, which was released today afternoon in Nature Communications, examined data from 6,907 people who had self-reported having Covid while taking part in 10 UK long-term health studies that had been started prior to the pandemic.
It examined the 1.1 million patients with Covid who had been given the diagnosis by the spring of last year.
Between 7.8% and 17% of the 6,907 trial participants reported having long-lasting Covid symptoms that lasted for more than 12 weeks, with 1.2% to 4.8% reporting having “debilitating” symptoms.
Only 0.4% of the 1.1 million Covid patients had a later lengthy Covid diagnostic or referral.